Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease. (2022)
Attributed to:
MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcac258
PubMed Identifier: 36382217
Publication URI: http://europepmc.org/abstract/MED/36382217
Type: Journal Article/Review
Volume: 4
Parent Publication: Brain communications
Issue: 6
ISSN: 2632-1297